Clinical Trials Directory

Trials / Completed

CompletedNCT04181697

HemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia A

The HemFitBit-study: Defining Normal Physical Activity in Haemophilia A

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Oslo University Hospital · Academic / Other
Sex
Male
Age
13 Years – 30 Years
Healthy volunteers

Summary

The study aims to describe physical activity (PA) levels in young people with haemophilia A in Norway compared with non-haemophilia controls, and to identify factors influencing PA. This will be conducted through an observational study measuring PA over 12 weeks. Forty young people with moderate and severe haemophilia A will be enrolled. PA data will be compared to demographically and seasonally matched non-haemophilia controls. PA will be measured using the activity tracker Fitbit Charge 3. A subgroup of participants will also wear the hip-worn accelerometer ActiGraph GTX+BT for seven consecutive days in order to validate the two devices against each other.

Conditions

Interventions

TypeNameDescription
DEVICEPA measurement with Fitbit Charge 3Measurement of PA with Fitbit for all participants and controls.
DEVICEPA measurement with Fitbit and ActiGraph GT3XMeasurement of PA with ActiGraph for a subgroup of 20 participants.

Timeline

Start date
2019-11-05
Primary completion
2020-08-27
Completion
2020-08-27
First posted
2019-11-29
Last updated
2020-11-30

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04181697. Inclusion in this directory is not an endorsement.

HemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia A (NCT04181697) · Clinical Trials Directory